LPL Financial’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$631K Sell
9,195
-6,821
-43% -$388K ﹤0.01% 4823
2026
Q1
$1.03M Buy
16,016
+6,157
+62% +$561K ﹤0.01% 4148
2025
Q4
$1.28M Buy
9,859
+1,083
+12% +$149K ﹤0.01% 3818
2025
Q3
$946K Sell
8,776
-45,926
-84% -$5M ﹤0.01% 4050
2025
Q2
$5.05M Buy
54,702
+11,597
+27% +$910K ﹤0.01% 2296
2025
Q1
$3.82M Buy
43,105
+7,484
+21% +$649K ﹤0.01% 2382
2024
Q4
$2.74M Buy
+35,621
New +$2.49M ﹤0.01% 2583

Other funds holding WGS

LPL Financial's WGS Position: Q2 2026 in Review

LPL Financial reduced its GeneDx Holdings (WGS) stake by 43% in Q2 2026, selling an estimated $388K and leaving 9,195 shares worth $631K. The position accounts for ﹤0.01% of the portfolio, ranked #4823.

LPL Financial first reported a position in WGS in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.05M in Q2 2025. 77 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • LPL Financial held 9,195 shares of GeneDx Holdings worth $631K as of Q2 2026.
  • LPL Financial sold 6,821 GeneDx Holdings shares in Q2 2026, an estimated $388K.
  • GeneDx Holdings made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #4823 holding.
  • LPL Financial first reported a position in GeneDx Holdings in Q4 2024 and has held it in 7 quarters since.
  • LPL Financial's GeneDx Holdings position peaked at $5.05M in Q2 2025.
  • 77 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.